Amgen Total Assets 2006-2019 | AMGN

Amgen total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Amgen total assets for the quarter ending March 31, 2019 were $63.997B, a 10.07% decline year-over-year.
  • Amgen total assets for 2018 were $66.416B, a 16.93% decline from 2017.
  • Amgen total assets for 2017 were $79.954B, a 3% increase from 2016.
  • Amgen total assets for 2016 were $77.626B, a 8.65% increase from 2015.
Amgen Annual Total Assets
(Millions of US $)
2018 $66,416
2017 $79,954
2016 $77,626
2015 $71,449
2014 $69,009
2013 $66,125
2012 $54,298
2011 $48,871
2010 $43,486
2009 $39,629
2008 $36,427
2007 $34,639
2006 $33,788
2005 $29,297
Amgen Quarterly Total Assets
(Millions of US $)
Q1 2019 $63,997
Q4 2018 $66,416
Q3 2018 $67,333
Q2 2018 $67,684
Q1 2018 $71,164
Q4 2017 $79,954
Q3 2017 $80,331
Q2 2017 $79,587
Q1 2017 $77,862
Q4 2016 $77,626
Q3 2016 $78,150
Q2 2016 $75,471
Q1 2016 $75,116
Q4 2015 $71,449
Q3 2015 $71,869
Q2 2015 $71,209
Q1 2015 $68,952
Q4 2014 $69,009
Q3 2014 $70,775
Q2 2014 $69,534
Q1 2014 $67,004
Q4 2013 $66,125
Q3 2013 $57,073
Q2 2013 $52,610
Q1 2013 $51,640
Q4 2012 $54,298
Q3 2012 $55,448
Q2 2012 $52,226
Q1 2012 $49,250
Q4 2011 $48,871
Q3 2011 $45,765
Q2 2011 $46,936
Q1 2011 $42,714
Q4 2010 $43,486
Q3 2010 $43,534
Q2 2010 $40,800
Q1 2010 $40,366
Q4 2009 $39,629
Q3 2009 $40,940
Q2 2009 $38,840
Q1 2009 $37,380
Q4 2008 $36,427
Q3 2008 $36,998
Q2 2008 $36,061
Q1 2008 $36,128
Q4 2007 $34,639
Q3 2007 $33,452
Q2 2007 $32,971
Q1 2007 $32,570
Q4 2006 $33,788
Q3 2006 $32,586
Q2 2006 $31,288
Q1 2006 $31,315
Q4 2005 $29,297
Q3 2005 $29,132
Q2 2005 $28,038
Q1 2005 $27,420
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $108.806B $23.747B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Gilead Sciences (GILD) United States $85.546B 10.39
Celgene (CELG) United States $68.622B 11.63
Illumina (ILMN) United States $51.613B 59.81
Biogen (BIIB) United States $44.941B 8.53
Vertex Pharmaceuticals (VRTX) United States $44.509B 53.80
Regeneron Pharmaceuticals (REGN) United States $33.983B 15.97
Alexion Pharmaceuticals (ALXN) United States $26.940B 15.25
Incyte (INCY) United States $17.550B 71.17
BioMarin Pharmaceutical (BMRN) United States $15.072B 0.00
Exact Sciences (EXAS) United States $14.452B 0.00
Seattle Genetics (SGEN) United States $11.552B 0.00
Array BioPharma (ARRY) United States $10.298B 0.00
Sarepta Therapeutics (SRPT) United States $9.423B 0.00
QIAGEN (QGEN) Netherlands $8.939B 29.36
Bio-Rad Laboratories (BIO.B) United States $8.674B 45.98
Bio-Techne Corp (TECH) United States $7.848B 53.55
Guardant Health (GH) United States $7.801B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.617B 0.00
Bluebird Bio (BLUE) United States $6.764B 0.00
Exelixis (EXEL) United States $6.235B 15.89
Amarin (AMRN) Ireland $6.204B 0.00
Galapagos (GLPG) Belgium $6.199B 0.00
Ascendis Pharma (ASND) Denmark $5.393B 0.00
BeiGene (BGNE) Cayman Islands $5.317B 0.00
Moderna (MRNA) United States $5.189B 0.00
Blueprint Medicines (BPMC) United States $4.614B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.051B 0.00
Spark Therapeutics (ONCE) United States $3.829B 0.00
China Biologic Products (CBPO) China $3.666B 23.28
ACADIA Pharmaceuticals (ACAD) United States $3.665B 0.00
Repligen (RGEN) United States $3.660B 91.18
Mirati Therapeutics (MRTX) United States $3.620B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.500B 0.00
Alkermes (ALKS) Ireland $3.480B 0.00
Allogene Therapeutics (ALLO) United States $3.330B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.113B 0.00
UniQure (QURE) Netherlands $3.067B 0.00
Global Blood Therapeutics (GBT) United States $3.059B 0.00
Arena Pharmaceuticals (ARNA) United States $2.837B 5.76
Amicus Therapeutics (FOLD) United States $2.779B 0.00
Lion Biotechnologies (IOVA) United States $2.711B 0.00
Medicines (MDCO) United States $2.647B 0.00
Reata Pharmaceuticals (RETA) United States $2.551B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.547B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.505B 0.00
Immunomedics (IMMU) United States $2.500B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.490B 0.00
Halozyme Therapeutics (HALO) United States $2.351B 0.00
Emergent Biosolutions (EBS) United States $2.329B 20.23
NeoGenomics (NEO) United States $2.301B 150.63
Akcea Therapeutics (AKCA) United States $2.263B 0.00
MyoKardia (MYOK) United States $2.204B 0.00
Ligand Pharmaceuticals (LGND) United States $2.190B 18.14
Acceleron Pharma (XLRN) United States $2.021B 0.00
Insmed (INSM) United States $1.965B 0.00
Genomic Health (GHDX) United States $1.931B 41.02
REGENXBIO (RGNX) United States $1.884B 0.00
Allakos (ALLK) United States $1.867B 0.00
Denali Therapeutics (DNLI) United States $1.867B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.856B 0.00
Myriad Genetics (MYGN) United States $1.817B 18.07
AnaptysBio (ANAB) United States $1.817B 0.00
Audentes Therapeutics (BOLD) United States $1.765B 0.00
Cambrex (CBM) United States $1.454B 18.38
Nabriva Therapeutics AG (NBRV) Ireland $1.443B 0.00
Innoviva (INVA) United States $1.441B 3.99
Alector (ALEC) United States $1.402B 0.00
Gossamer Bio (GOSS) United States $1.390B 0.00
Apellis Pharmaceuticals (APLS) United States $1.382B 0.00
Coherus BioSciences (CHRS) United States $1.356B 0.00
Aimmune Therapeutics (AIMT) United States $1.284B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.255B 0.00
Fate Therapeutics (FATE) United States $1.246B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.243B 0.00
Eidos Therapeutics (EIDX) United States $1.209B 0.00
Athenex (ATNX) United States $1.194B 0.00
Rubius Therapeutics (RUBY) United States $1.150B 0.00
Epizyme (EPZM) United States $1.128B 0.00
Sangamo Therapeutics (SGMO) United States $1.126B 0.00
Editas Medicine (EDIT) United States $1.113B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.082B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.040B 0.00
CORTEXYME INC (CRTX) United States $1.026B 0.00
Atara Biotherapeutics (ATRA) United States $1.022B 0.00
Codexis (CDXS) United States $0.970B 0.00
RA PHARMCTL INC (RARX) United States $0.962B 0.00
WAVE Life Sciences (WVE) Singapore $0.940B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.928B 0.00
NGM Biopharmaceuticals (NGM) United States $0.918B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.881B 0.00
ANI Pharmaceuticals (ANIP) United States $0.873B 15.49
Inotek Pharmaceuticals (RCKT) United States $0.851B 0.00
Principia Biopharma (PRNB) United States $0.841B 0.00
Twist Bioscience (TWST) United States $0.826B 0.00
Retrophin (RTRX) United States $0.822B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.789B 37.25
Cara Therapeutics (CARA) United States $0.789B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.786B 0.00
Intra-Cellular Therapies (ITCI) United States $0.780B 0.00
Axsome Therapeutics (AXSM) United States $0.772B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.771B 0.00
Clovis Oncology (CLVS) United States $0.748B 0.00
Kura Oncology (KURA) United States $0.744B 0.00
G1 THERAPEUTICS (GTHX) United States $0.740B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.731B 0.00
Adverum Biotechnologies (ADVM) United States $0.730B 0.00
Vericel (VCEL) United States $0.725B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.711B 0.00
Arvinas (ARVN) United States $0.709B 0.00
MeiraGTx Holdings (MGTX) United States $0.691B 0.00
Myovant Sciences (MYOV) United Kingdom $0.677B 0.00
Intellia Therapeutics (NTLA) United States $0.671B 0.00
Zymeworks (ZYME) Canada $0.662B 0.00
Stemline Therapeutics (STML) United States $0.655B 0.00
Zealand Pharma (ZEAL) Denmark $0.643B 7.51
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.637B 0.00
Precision BioSciences (DTIL) United States $0.632B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.627B 0.00
Cytokineticsorporated (CYTK) United States $0.621B 0.00
Heska (HSKA) United States $0.610B 62.48
Cellectis (CLLS) France $0.607B 0.00
Viking Therapeutics (VKTX) United States $0.586B 0.00
Anika Therapeutics (ANIK) United States $0.576B 19.67
Puma Biotechnology (PBYI) United States $0.526B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.525B 0.00
Revance Therapeutics (RVNC) United States $0.498B 0.00
Scholar Rock Holding (SRRK) United States $0.494B 0.00
DBV Technologies (DBVT) France $0.492B 0.00
BeyondSpring (BYSI) United States $0.489B 0.00
CytomX Therapeutics (CTMX) United States $0.489B 0.00
UROGEN PHARMA (URGN) United States $0.489B 0.00
Mesoblast (MESO) Australia $0.465B 0.00
Magenta Therapeutics (MGTA) United States $0.460B 0.00
ObsEva SA (OBSV) Switzerland $0.457B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.456B 0.00
Synthorx (THOR) United States $0.450B 0.00
Sorrento Therapeutics (SRNE) United States $0.446B 0.00
Kodiak Sciences (KOD) United States $0.443B 0.00
Provention Bio (PRVB) United States $0.424B 0.00
Krystal Biotech (KRYS) United States $0.415B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.413B 0.00
Replimune (REPL) United States $0.413B 0.00
Kaleido Biosciences (KLDO) $0.412B 0.00
MediciNova (MNOV) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.403B 0.00
UNITY Biotechnology (UBX) $0.393B 0.00
AC Immune SA (ACIU) Switzerland $0.392B 25.22
Prothena (PRTA) Ireland $0.388B 0.00
BioDelivery Sciences (BDSI) United States $0.387B 0.00
Agenus (AGEN) United States $0.387B 0.00
Albireo Pharma (ALBO) United States $0.384B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.378B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Acorda Therapeutics (ACOR) United States $0.370B 6.51
Gritstone Oncology (GRTS) United States $0.368B 0.00
PDL BioPharma (PDLI) United States $0.358B 8.54
Biofrontera AG Sponsored ADR (BFRA) Germany $0.358B 0.00
Senesco Technologies (ELOX) United States $0.355B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.343B 0.00
ResTORbio (TORC) United States $0.338B 0.00
NEXTCURE INC (NXTC) United States $0.332B 0.00
AVROBIO (AVRO) United States $0.326B 0.00
Kindred Biosciences (KIN) United States $0.320B 0.00
LogicBio Therapeutics (LOGC) United States $0.313B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.305B 0.00
Merus (MRUS) Netherlands $0.302B 0.00
PHASEBIO PHARMA (PHAS) United States $0.301B 0.00
Cyclerion Therapeutics (CYCN) United States $0.295B 0.00
Palatin Technologies (PTN) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.274B 0.00
Geron (GERN) United States $0.274B 0.00
Athersys (ATHX) United States $0.274B 0.00
Syros Pharmaceuticals (SYRS) United States $0.272B 0.00
Dynavax Technologies (DVAX) United States $0.267B 0.00
Abeona Therapeutics (ABEO) United States $0.264B 0.00
XBiotech (XBIT) United States $0.263B 0.00
Chiasma (CHMA) United States $0.257B 0.00
Sutro Biopharma (STRO) United States $0.255B 0.00
Inovio Pharmaceuticals (INO) United States $0.253B 0.00
Constellation Pharmaceuticals (CNST) United States $0.248B 0.00
Urovant Sciences (UROV) United States $0.247B 0.00
Synlogic (SYBX) United States $0.241B 0.00
Evelo Biosciences (EVLO) United States $0.241B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.240B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.235B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.234B 0.00
Five Prime Therapeutics (FPRX) United States $0.232B 0.00
MannKind (MNKD) United States $0.231B 0.00
Neothetics (EVFM) United States $0.230B 0.00
Celcuity (CELC) United States $0.230B 0.00
AXCELLA HEALTH (AXLA) United States $0.229B 0.00
Kadmon Holdings (KDMN) United States $0.225B 0.00
Kamada (KMDA) Israel $0.221B 8.58
Cerecor (CERC) United States $0.220B 0.00
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
Avid Bioservices (CDMO) United States $0.220B 0.00
ChromaDex (CDXC) United States $0.219B 0.00
Pfenex (PFNX) United States $0.219B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.214B 0.00
IDEAYA BIOSCI (IDYA) United States $0.213B 0.00
Enochian BioSciences (ENOB) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.210B 0.00
Cel-Sci (CVM) United States $0.206B 0.00
Enzo Biochem (ENZ) United States $0.204B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.202B 0.00
Affimed (AFMD) Germany $0.202B 0.00
Kala Pharmaceuticals (KALA) United States $0.190B 0.00
Mersana Therapeutics (MRSN) United States $0.187B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.183B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 10.41
Compugen (CGEN) Israel $0.178B 0.00
Solid Biosciences (SLDB) United States $0.177B 0.00
HOOKIPA PHARMA (HOOK) United States $0.177B 0.00
Gamida Cell (GMDA) Israel $0.174B 0.00
CorMedix Inc (CRMD) United States $0.173B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
OvaScience (MLND) United States $0.170B 0.00
Dyadic (DYAI) United States $0.167B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.167B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
Liquidia Technologies (LQDA) United States $0.162B 0.00
OSMOTICA PHARM (OSMT) United States $0.159B 0.00
Anavex Life Sciences (AVXL) United States $0.158B 0.00
Intec Pharma (NTEC) Israel $0.158B 0.00
Kezar Life Sciences (KZR) United States $0.155B 0.00
APPLIED THERAPT (APLT) United States $0.154B 0.00
BioTime (BTX) United States $0.154B 10.30
Checkpoint Therapeutics (CKPT) United States $0.153B 0.00
Mustang Bio (MBIO) United States $0.152B 0.00
Aduro Biotech (ADRO) United States $0.151B 0.00
Menlo Therapeutics (MNLO) United States $0.151B 0.00
XOMA (XOMA) United States $0.149B 0.00
SESEN BIO, INC (SESN) United States $0.143B 0.00
TOCAGEN INC (TOCA) United States $0.138B 0.00
TREVI THERAPTCS (TRVI) United States $0.137B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
Verastem (VSTM) United States $0.129B 0.00
Eton Pharmaceuticals (ETON) United States $0.127B 0.00
Axovant Sciences (AXGT) United States $0.126B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.124B 0.00
VolitionRX (VNRX) Singapore $0.121B 0.00
Novavax (NVAX) United States $0.120B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Fortress Biotech (FBIO) United States $0.116B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Aptose Biosciences (APTO) Canada $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.106B 0.00
INmune Bio (INMB) United States $0.106B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.105B 0.00
Equillium (EQ) United States $0.104B 0.00
Arbutus Biopharma (ABUS) Canada $0.103B 0.00
NantKwest (NK) United States $0.103B 0.00
Trevena (TRVN) United States $0.103B 0.00
Aptinyx (APTX) United States $0.101B 0.00
Seres Therapeutics (MCRB) United States $0.101B 0.00
Selecta Biosciences (SELB) United States $0.099B 0.00
Allena Pharmaceuticals (ALNA) United States $0.098B 0.00
Catalyst Biosciences (CBIO) United States $0.090B 0.00
InflaRx (IFRX) Germany $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Unum Therapeutics (UMRX) United States $0.078B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.075B 0.00
Cohbar (CWBR) United States $0.075B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.073B 0.00
Signal Genetics (MGEN) United States $0.073B 0.00
Applied Genetic Technologies (AGTC) United States $0.073B 39.90
VTv Therapeutics (VTVT) United States $0.072B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Cocrystal Pharma (COCP) United States $0.070B 73.33
Orgenesis (ORGS) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.066B 0.00
OVID THERAPEUTC (OVID) United States $0.065B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Alcobra (ARCT) United States $0.065B 0.00
Hoth Therapeutics (HOTH) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
VBI Vaccines (VBIV) United States $0.063B 0.00
ScPharmaceuticals (SCPH) United States $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Eyenovia (EYEN) United States $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
Moleculin Biotech (MBRX) United States $0.052B 0.00
Ophthotech (ISEE) United States $0.052B 0.00
Zosano Pharma (ZSAN) United States $0.050B 0.00
Curis (CRIS) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.049B 0.00
Apricus Biosciences (SEEL) United States $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Entera Bio (ENTX) Israel $0.043B 0.00
Cidara Therapeutics (CDTX) United States $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
VIVUS (VVUS) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
AZURRX BIOPHARM (AZRX) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.032B 0.00
Edge Therapeutics (PDSB) United States $0.032B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.031B 0.00
Aytu Bioscience (AYTU) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Bison Capital Acquisition (XYN) China $0.025B 0.00
Histogenics (HSGX) United States $0.023B 0.00
Oragenics (OGEN) United States $0.023B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
GTx (ONCT) United States $0.022B 0.00
Sophiris Bio (SPHS) United States $0.021B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Vical (VICL) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
OncoSec Medical (ONCS) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.014B 0.00
Aileron Therapeutics (ALRN) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Motif Bio Plc (MTFB) United States $0.012B 0.00
Advaxis (ADXS) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
Therapix Biosciences (TRPX) Israel $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
IMMURON LTD (IMRN) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Neuralstem (CUR) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
AmpliPhi Biosciences (ARMP) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00